Sangrix issues 75,000 Class B shares to CEO

Sangrix Inc. (SGRX) issued 75,000 Class B Ordinary Shares to Jinghai Jiang, its Chairman of the Board, Chief Executive Officer and Chief Operating Officer, on October 21, 2026.

Rhea-AI Filing Summary

Sangrix Inc. (SGRX) issued 75,000 Class B Ordinary Shares to Jinghai Jiang, its Chairman of the Board, Chief Executive Officer and Chief Operating Officer, on October 21, 2026. The shares have a par value of $0.0003 each and were sold at $0.4390 per share, for aggregate consideration of $32,925.00. The board and Audit Committee approved the issuance.

Following the issuance, Jiang will hold 100% of Sangrix’s outstanding Class B ordinary shares, representing approximately 35% of the total voting power of its issued and outstanding share capital. The SPA and issuance were made pursuant to the exemption from registration under Section 4(a)(2) of the Securities Act and Regulation S.

Key Figures

Class B Ordinary Shares issued: 75,000 shares Purchase price: $0.4390 per share Aggregate consideration: $32,925.00 +3 more

6 metrics

Class B Ordinary Shares issued 75,000 shares Issued to Jinghai Jiang on October 21, 2026

Purchase price $0.4390 per share Price for the Class B Ordinary Shares

Aggregate consideration $32,925.00 Consideration for the 75,000 shares

Par value $0.0003 per share Class B Ordinary Shares

Ownership of outstanding Class B ordinary shares 100% Jinghai Jiang following the issuance

Total voting power Approximately 35% Jinghai Jiang following the issuance

Key Terms

par value, Section 4(a)(2), Regulation S

3 terms

par value financial

"Class B Ordinary Shares, par value $0.0003 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

Section 4(a)(2) regulatory

"exemption from registration contained in Section 4(a)(2)"

Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.

Regulation S regulatory

"Regulation S promulgated thereunder"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did SGRX issue to Jinghai Jiang, and at what price?

Sangrix issued 75,000 Class B Ordinary Shares to Jinghai Jiang at $0.4390 per share on October 21, 2026, for aggregate consideration of $32,925.00. Jiang is the Company's Chairman of the Board, Chief Executive Officer and Chief Operating Officer.

What voting power will Jinghai Jiang have after the SGRX share issuance?

Following the issuance, Jinghai Jiang will hold 100% of Sangrix's outstanding Class B ordinary shares, representing approximately 35% of the total voting power of its issued and outstanding share capital.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/22/2026 - 04:31 PM EDT Accepted by SEC EDGAR 10/22/2026 - 04:30 PM EDT Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2026

Commission File Number: 001-38857

SANGRIX INC.

(Translation of registrant’s name into English)

160 Robinson Road 

12F, SBF Center 

Singapore 068914

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x    Form 40-F ¨

On October 21, 2026, the Company entered into a securities purchase agreement (“the SPA”) with Jinghai Jiang, the Chairman of the Board, Chief Executive Officer, Chief Operating Officer of the Company (the “Buyer”). Pursuant to the SPA, the Company agreed to issue and sell to the Buyer 75,000 Class B Ordinary Shares, par value $0.0003 per share, at a purchase price of $0.4390 per share, for aggregate consideration of $32,925.00. The issuance have been approved by the Board of Directors and the Audit Committee.

On October 21, 2026, the Company issued 75,000 Class B Ordinary Shares to the Buyer. Following the issuance, the Buyer will hold 100% of the Company's outstanding Class B ordinary shares, representing approximately 35% of the total voting power of the Company's issued and outstanding share capital.

The execution and delivery of the SPA and the issuance of the Class B Ordinary Shares were made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended, and Regulation S promulgated thereunder.

The foregoing description of the SPA is qualified in its entirety by reference to the provisions of the SPA filed as Exhibit 10.1 to this report, which is incorporated by reference herein.

This report on Form 6-K is incorporated by reference into the Company’s Registration Statement on Form F-3 initially filed with the Securities and Exchange Commission on November 16, 2023 (Registration No. 333-275602), as amended, and the Company’s Registration Statement on Form F-3 initially filed with the Securities and Exchange Commission on August 13, 2024 (Registration No. 333-281518).

EXHIBIT INDEX

Exhibit No.		Description
10.1		Securities Purchase Agreement by and between the Company and Jinghai Jiang, dated October 21, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	SANGRIX INC.
Date: October 22, 2026	By:	/s/ Jinghai Jiang
	Name:	Jinghai Jiang
	Title:	Chairman of the Board, Chief Executive Officer, Chief Operating Officer

Filing Exhibits & Attachments

1 document

Agreements & Contracts

• EX-10.1 EXHIBIT 10.1 74.3 KB